Whereas there is a multitude of studies on the effects of microgravity on peripheral blood pressure, this study provides first data on central aortic blood pressure. An acute loss of gravity leads to a central blood volume shift with an augmentation of cardiac output. In healthy subjects with normal arterial stiffness, the compensatory decrease of peripheral resistance does not outweigh this effect resulting in an increase of central blood pressure.
Blood pressure has been traditionally measured at peripheral arteries. In the past decade, however, there is increasing evidence that central aortic blood pressure might be superior to peripheral blood pressure in the prediction of cardiovascular events. The ASCOT and its substudy CAFE demonstrated the impact of central blood pressure on the risk of stroke. 1, 2 Data on the regulation of central aortic pressure, however, are rare.
The transition to microgravity is an interesting model to study the regulation of blood pressure. Gravity leads to blood pooling in the lower part of the body. Without a compensatory peripheral vasoconstriction, gravity would cause cerebral hypoperfusion with a rapid loss of conscience. Transition to microgravity leads to a central blood volume shift with compensatory immediate vasodilation. The effects on peripheral blood pressure have been studied extensively. [3] [4] [5] An examination of central aortic pressure was not possible so far because the technical prerequisites for a noninvasive reliable and rapid assessment during short periods of microgravity were lacking. The recent development of cuff-based oscillometric instead of tonometric pulse wave analysis technologies now allows an assessment of central aortic pressure in a few seconds of microgravity for the first time. Besides providing physiological insights, the examination of central blood pressure in microgravity is of interest for space agencies, who are interested in medical safety of envisioned long-term stays in microgravity in the future.
In analogy to peripheral blood pressure, central aortic blood pressure is supposed to be a 2-component system, built out of a forward and a reflected pulse wave. 6 In healthy subjects, the reflected pulse wave returns to peripheral arteries during systole and to the central aorta during diastole. Thus, the microgravity-induced abrupt vasodilation might have a differential impact on peripheral and central arterial pressure. The present study investigates the effect of short-term microgravity on central blood pressure during parabolic flights.
METHODS

Study population
The study protocol received an approval by the institutional committee of the Ruhr University Bochum (register number 5158-14). Twenty apparently healthy subjects were recruited. Intake of any kind of medication on a regular basis and a history of cardiovascular disease including hypertension, diabetes, coronary heart disease, congestive heart failure, and stroke were defined as exclusion criterion. Median age was 25 years ranging from 19 
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Blood pressure has been traditionally measured at peripheral arteries. In the past decade, evidence has grown that central aortic blood pressure may be a more powerful predictor for cardiovascular events, but data on its regulation are rare. The present work examines the impact of microgravity on central blood pressure for the first time.
METHODS
We performed 7 parabolic flights with 22 seconds of weightlessness in each parabola. Hemodynamic parameters including central systolic blood pressure were measured noninvasively in a free-floating position in 20 healthy subjects (19-43 years of age).
RESULTS
Arterial elasticity at rest was normal in all participants (augmentation index 14% (interquartile range (IQR) 10-22), pulse wave velocity 5.2 m/s (IQR 5.0-5.4)). Transition of 1g to 0g led to a significant increase of central systolic blood pressure from 124 (IQR 118-133) to 127 (IQR 119-133) mm Hg (P = 0.017). Cardiac index augmented significantly from 2.5 (IQR 2.2-2.8) to 2.7 (IQR 2.3-3.0) l/min/m 2 (P < 0.001), while peripheral vascular resistance showed a decrease from 1.30 (IQR 1.14-1.48) to 1.25 (IQR 1.15-1.40) s × mm Hg/ml (P = 0.037). Peripheral systolic blood pressure did not change significantly (P > 0.05).
participant passed a predefined parabolic flight medical examination, which was part of the requirements of the parabolic flight executing company Novespace. All subjects provided a written informed consent. Heavy exercise and alcohol were strictly prohibited starting the day before testing. Participants of parabolic flights usually receive a premedication with scopolamine to prevent kinetosis. In order to avoid any drug-related hemodynamic effects, we refrained from any medication. Instead, subjects with obvious kinetosis (vomiters) were refrained from hemodynamic measurements.
Parabolic flights
Microgravity was created by parabolic flight maneuvers, which took place in Bordeaux, France. An Airbus A310 performed 31 parabolas per flight in order to achieve 0g environment for 22 seconds each. The study was part of 2 entire parabolic flight campaigns with 1 flight per day, which was preceded by a preflight ground preparation phase. A total of 7 flights took place with a sum of 217 successfully flown parabolas. During the phases of microgravity, the g-level was kept <0.05g. The cabin conditions remained stable at all time with a pressure of 830 millibar, cabin luminosity of 800 lux, and a temperature of 19-21 °C with a humidity of 15%. The parabolas were performed in 6 sets of 5 parabolas-a test parabola (parabola "n°0") preceded the first set. Each set was separated by a pause of 5 to 8 minutes. Steady flight in 1g between 2 parabolas lasted for 2 minutes. One parabola started with a "pull-up"-phase of around 20 seconds, followed by 22 seconds of microgravity, and finalizing the maneuver with the "pull-out"-phase of another 20 seconds in order to reach a steady flight. Gravity in "pull-up" and "pull-out" phases reached 1.5g up to 1.8g. During 1 parabolic flight, 3 test subjects were able to be investigated. They were accompanied by 2 operators in order to stabilize all test subjects body position during microgravity. Normal gravity (1g) and hypergravity phases (1.5-1.8g) were done in a lying position. In order to avoid any abrupt movement during microgravity, free floating was restricted through a 4-point fixation (captive floating). The first campaign provided data in each microgravity phase. The second campaign was able to provide 1g to 0g comparison for each parabola.
Hemodynamic measurements
Noninvasive measurement of central aortic blood pressure was performed by the Mobil-O-Graph device (I.E.M., Stolberg, Germany). Beyond the oscillometric measurement of peripheral blood pressure, this device performs a tonometric contour analysis of the brachial arterial pulse wave and thereby allows an assessment of the central aortic blood pressure, cardiac index, peripheral vascular resistance, augmentation index, and pulse wave velocity. Augmentation index is calculated as "augmentation index (%) = (augmentation pressure/pulse pressure) × 100. " The device has been validated by a comparison with intra-arterial measurements 7, 8 and an established tonometric method. 9, 10 Due to the short period of microgravity (maximum of 22 seconds), only pulse wave analysis can be performed with the Mobil-O-Graph.
Median peripheral blood pressure values (systole and diastole) of a beat-to-beat measurement from seconds 10 to 20 of each parabola were implemented in the waveform assessment in order to calculate the actual central aortic pressure. Continuous documentation of peripheral blood pressure was obtained photoplethysmographically by the SOMNOTouch NIBP (Somnomedics, Randersacker, Germany). Calibration at start of the device was done with the oscillometric results of the Mobil-O-Graph. The SomnoTouch NIBP has been validated by the highest requirements of the European Society of Hypertension and shows excellent results when compared with cuff-based and intra-arterial measurements. [11] [12] [13] In order to prove reliable peripheral blood pressure assessment over time and in accordance with the Mobil-O-Graph, we compared blood pressure values of the SomnoTouch NIBP with reference measurements of the Mobil-O-Graph over a time period of 60 minutes. Statistical analysis with Bland-Altmann showed a solid and dependable continuous peripheral blood pressure measurement with excellent concordance to the Mobil-O-Graph over time (stable bias of 0.8-1.1 mm Hg for systolic and 0.7-1.4 mm Hg for diastolic blood pressure; Supplementary Appendix). Data of parabolas with insufficient signal quality due to artefacts were discarded from statistical analysis following a quality score from the software.
Statistics
Data were analyzed for Gaussian distribution using the D' Agostino and Pearson test. Since all data except augmentation index showed a non-Gaussian distribution, data are presented as median and interquartile range (IQR), and statistical analyses were performed nonparametrically. An analysis of variance (Kruskal-Wallis) was used to test for significant changes of numeric parameters in the course of flight (sets). Post-hoc analyses were performed by Dunn's post-hoc test. Changes of hemodynamic parameters in the transition from 1g to 0g were analyzed using the Wilcoxon test. P < 0.05 was regarded as statistically significant. All statistical analyses were done using Prism 6 (GraphPad Software, La Jolla, CA).
RESULTS
Baseline hemodynamics
Twenty healthy test subjects were enrolled in the study including 11 males and 9 females with a median age of 25 (IQR 22-29). Arterial elasticity was normal in all participants: augmentation index 14% (IQR 10-22) and pulse wave velocity 5.2 m/s (IQR 5.0-5.4). All hemodynamic parameters at rest are summarized in Table 1 .
Hemodynamic parameters in the course of subsequent microgravity phases
Four out of 20 test subjects suffered from kinetosis and were excluded from analysis. Results of hemodynamic measurements in microgravity are resumed in Table 2 . The course of median peripheral as well as central blood pressure along the microgravity sets are presented in Figure 1 . Peripheral systolic blood pressure decreased significantly in the course of the 6 sets (P = 0.001), while central systolic blood pressure remained statistically unchanged (P = 0.24). Post-hoc analysis by Dunn revealed a significant difference in peripheral blood pressure between the first and the last set of parabolas (135 (IQR 122-144) vs. 125 (IQR 118-132) mm Hg, P = 0.005). Both peripheral and central diastolic blood pressure remained unchanged from set 1 to set 6. The test subjects' heart rates decreased from 94 to 87/min (P = 0.017, Figure 2 ). Augmentation pressure and augmentation index were stable throughout the 6 sets of parabolas (P = 0.98 and P = 0.97, respectively, Figure 2) . Pulse wave velocity, cardiac index, as well as peripheral vascular resistance did not alter significantly along the 30 parabolas (P = 0.55, P = 0.57, P = 0.99, respectively, Figure 2) Transition from 1g to 0g
Hemodynamic properties in 1g and 0g are provided in Table 2 
<0.001
Pulse wave velocity (m/s) 
0.037
The left part of the table presents 0g data out of the first and the second parabolic flight campaigns. Shifts from 1g to 0g are shown on the right-hand side of the table. Data are presented as median and interquartile range. Interset differences in hemodynamic parameters were analyzed by Kruskal-Wallis tests, differences from 1g to 0g by Wilcoxon paired tests. Abbreviations: cDBP, central diastolic blood pressure; cSBP, central systolic blood pressure; pDBP, peripheral diastolic blood pressure; pSBP, peripheral systolic blood pressure. One set consists of 5 parabolas, the first set being preceded by a parabola "n°0." One flight encompasses 6 sets, resulting in 31 parabolas per flight. P < 0.05 was regarded significant (bold type).
constant at 3 mm Hg (IQR 2-6 mm Hg for both, P = 0.90). Cardiac index augmented from 2. 
DISCUSSION
The present study constitutes the first examination of central blood pressure in microgravity. We used parabolic flights to create short-term microgravity. Human experimentation in 0g for a longer lapse of time is not possible on earth. Invasive catheter-based intra-aortic blood pressure measurement would imply a highly life-threatening risk in this experimental setting. Hence, we applied the best technical way there is to date, in order to obtain a reliable noninvasive assessment of central blood pressure in microgravity.
Our data show a small but significant increase of central aortic pressure during short-term periods of microgravity. Noteworthy, by using a signed-rank test, we demonstrate, which even being numerically humble, there is a clear statistical predominance of an increase in central blood pressure. Beyond central and peripheral blood pressure, the present study obtained data on cardiac index and peripheral vascular resistance in microgravity. These measurements were performed in order to provide insight into the hemodynamic mechanisms underlying changes of blood pressure in the transition from 1g to 0g. The acute onset of microgravity induced an increase of cardiac output. Studies using a gas rebreathing method or ballistocardiography support this increase of cardiac output as a consequence of a central volume shift. 5, 14 The increase of cardiac index was followed by a compensatory reduction of heart rate and a peripheral vasodilation, which have to be interpreted as an autoregulatory attempt to maintain intra-arterial pressure stable. The vasodilation was documented by the decrease of peripheral vascular resistance in the present data.
A peripheral vasodilation, however, affects arterial blood pressure by 2 phenomena: First, it diminishes peripheral vascular resistance, thereby directly reducing intra-arterial pressure. Second, it ameliorates the amplitude of the reflected pulse wave. In young healthy subjects, the reflected wave augments peripheral arterial blood pressure to a lesser extent, than central arterial blood pressure. Hence, the microgravity-induced vasodilation with consequently diminished wave reflection had a stronger impact on peripheral than on central arterial blood pressure. In the aorta, the peripheral vasodilation did obviously not outweigh the effects of the increase of cardiac output on systolic blood pressure. The present findings thereby render further support to the 2-component model of central arterial blood pressure. 6 The baseline examination of pulse wave velocity documents that the present young study population had indeed a normal arterial elasticity. In elderly subjects with stiff arteries, pulse wave velocity is substantially higher leading to an augmentation of systolic blood pressure by the reflected pulse wave and resulting in the phenotype of an "isolated systolic hypertension. " It remains elusive, whether the reactive vasodilation after transition from 1g to 0g would outweigh the increase of cardiac output in these subjects. In this case, the increase of central blood pressure would be less pronounced. Unfortunately, it appears quite improbable that elderly subjects with isolated systolic hypertension will participate in parabolic flights or enter the International Space Station (ISS) in the near future. Nevertheless, the uprising sector of commercial space flights will surely add a new kind of vascular phenotype to the astronaut population, which is, to date, exclusively well trained and in perfect health. Hence, this question will remain open for the time being.
Central blood pressure and aortic pulse pressure have a stronger association with coronary heart disease, atherosclerosis, and left ventricular mass than brachial blood pressure. [15] [16] [17] [18] Moreover, brachial blood pressure is inferior to central blood pressure in the prediction of cardiovascular events, end-stage renal disease, and all-cause mortality. 17, [19] [20] [21] [22] Current technical solutions have simplified the noninvasive measurement of central aortic blood pressure substantially. Several manufacturers offer devices that perform pulse wave analysis by a usual upper-arm cuff and do not require an additional hand-operated tonometric examination anymore. These techniques could be implemented in daily clinical practice. Thus, basing antihypertensive treatment decisions on central rather than on brachial pressure may be feasible in the close future. It is currently under consideration, whether integration of central blood pressure measurement is feasible in the biomonitoring of astronauts working on the ISS. This idea should be welcomed because our data from parabolic flight experiments only describe the short-term effects of microgravity on central blood pressure. Space agencies also need information on long-term effects to assess medical safety of envisioned extraterrestrial habitations in the future.
Microgravity led to an increase of aortic blood pressure by 3 mm Hg. But are 3 mm Hg clinically relevant? In the ASCOT-BPLA trial, fewer patients on the amlodipine-based regimen suffered from cardiovascular events compared with the atenolol-based therapy. The mean systolic blood pressure difference in the 5.5-year follow-up phase was 2.7 mm Hg. 1 The substudy CAFE revealed a difference of 4.3 mm Hg for central blood pressure. These differences translated into a significantly lower incidence of cardiovascular events in the follow-up period of 4 years. 2 If the observed increase in central aortic blood pressure would be maintained in long-term microgravity, it might indeed be of relevance. There are already some hints for a potentially increased cardiovascular risk during long-term stays in space today: Space radiation gives rise to the most frequent radiogenetic cancer i.e., leukemia. But radiation is also deleterious to blood vessel elasticity. Cancer patients, who underwent radiotherapy, have proven to lose arterial compliance in the treated area. 23 Evidence grows, that radiation may play a pathophysiological role in vascular damage during space flight as well. 24 Indeed, central arteries of astronauts develop thicker intima media and become significantly stiffer after just a couple of months in space. 25, 26 The main limitation of our study is the small study population, which is the consequence of the highly restrictive availability of parabolic flights. Furthermore, only parabolic flight novices were enrolled and had to deal with the challenging environment of microgravity. Additional studies with experienced test subjects would be welcomed in order to decrease the effects of psychomotoric activation. It cannot be excluded that the accuracy of photoplethysmography might be slightly affected by a change of hemodynamics in microgravity. However, the applied technique to assess central blood pressure changes in microgravity is the best available option at this moment.
In conclusion, the present study provides first in man data on the effects of acute microgravity on central aortic blood pressure. Our data show that an acute loss of gravity leads to a central blood volume shift with an augmentation of cardiac output. In healthy subjects with normal arterial stiffness, the compensatory decrease of peripheral resistance does not outweigh this effect resulting in an increase of central blood pressure. An implementation of cuff-based central aortic blood pressure measurement to the biomonitoring of astronauts on the ISS should be welcomed in order to assess the long-term effects. For the present, the authors will refrain from long-term flights to the outer rim of the universe.
SUPPLEMENTARY DATA
Supplementary data are available at American Journal of Hypertension online.
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